C-MER Medical Holdings active in share repurchases

C-MER Medical Holdings Limited (03309) submitted a Next Day Disclosure Return on November 28, 2025, detailing changes in its issued and treasury shares. The company repurchased 220,000 ordinary shares on the Exchange on November 28, 2025, at prices ranging from HKD 1.73 to HKD 1.74, with an aggregate price paid of HKD 381,300. These shares are being held as treasury shares, increasing the total number of treasury shares from 17,568,000 to 17,788,000. This repurchase represents 0.0178% of the existing number of issued shares before the event. The total number of issued shares (excluding treasury shares) decreased from 1,237,992,870 to 1,237,772,870.

The report also lists numerous share repurchases for cancellation that have not yet been cancelled, spanning from July 12, 2024, to May 15, 2025. These repurchases range from 38,000 to 1,000,000 shares per event, with varying prices. For instance, on July 12, 2024, 186,000 shares were repurchased at HKD 2.64, while on May 15, 2025, 300,000 shares were repurchased at HKD 1.6997.

The company's repurchase mandate was granted on May 19, 2025, authorizing the repurchase of up to 125,556,087 shares. The 220,000 shares repurchased on November 28, 2025, represent 0.0178% of the authorized amount. A moratorium period for new share issues or sales of treasury shares is in effect until December 28, 2025.